BTIG Research Reiterates “Buy” Rating for FIGS (NYSE:FIGS)

FIGS (NYSE:FIGS)‘s stock had its “buy” rating reissued by research analysts at BTIG Research in a research report issued to clients and investors on Friday,Benzinga reports. They currently have a $15.00 price objective on the stock. BTIG Research’s price objective suggests a potential downside of 2.82% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the company. Telsey Advisory Group reaffirmed a “market perform” rating and set a $15.00 target price (up from $9.00) on shares of FIGS in a research report on Friday, February 20th. Weiss Ratings restated a “hold (c-)” rating on shares of FIGS in a research note on Monday, December 29th. The Goldman Sachs Group raised their target price on shares of FIGS from $5.50 to $7.50 and gave the company a “sell” rating in a research note on Friday, January 30th. Morgan Stanley lifted their target price on shares of FIGS from $7.50 to $8.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 13th. Finally, Wolfe Research upgraded shares of FIGS to a “buy” rating in a report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $12.25.

FIGS Trading Up 23.8%

Shares of NYSE:FIGS opened at $15.44 on Friday. The stock has a market capitalization of $2.54 billion, a PE ratio of 81.24 and a beta of 1.29. FIGS has a 1 year low of $3.57 and a 1 year high of $15.90. The firm has a fifty day moving average price of $11.39 and a 200 day moving average price of $9.37.

FIGS (NYSE:FIGS) last posted its earnings results on Thursday, February 26th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.08. The company had revenue of $201.90 million for the quarter, compared to analyst estimates of $165.33 million. FIGS had a return on equity of 8.62% and a net margin of 5.43%.The business’s revenue was up 33.0% compared to the same quarter last year. During the same period last year, the company earned $0.01 earnings per share. On average, sell-side analysts forecast that FIGS will post 0.01 earnings per share for the current fiscal year.

Insider Activity at FIGS

In other FIGS news, CEO Catherine Eva Spear sold 49,734 shares of the company’s stock in a transaction that occurred on Tuesday, January 6th. The stock was sold at an average price of $11.38, for a total value of $565,972.92. Following the completion of the transaction, the chief executive officer owned 1,857,299 shares of the company’s stock, valued at $21,136,062.62. This represents a 2.61% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Heather L. Hasson sold 22,874 shares of FIGS stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total value of $241,549.44. Following the sale, the insider directly owned 1,251,967 shares in the company, valued at $13,220,771.52. The trade was a 1.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 105,813 shares of company stock worth $1,168,051 over the last three months. Company insiders own 29.44% of the company’s stock.

Institutional Investors Weigh In On FIGS

Institutional investors and hedge funds have recently bought and sold shares of the business. Invesco Ltd. raised its stake in shares of FIGS by 135.9% in the 4th quarter. Invesco Ltd. now owns 503,470 shares of the company’s stock valued at $5,719,000 after buying an additional 290,052 shares in the last quarter. Corient Private Wealth LLC increased its stake in FIGS by 6.3% in the fourth quarter. Corient Private Wealth LLC now owns 350,694 shares of the company’s stock valued at $3,984,000 after acquiring an additional 20,843 shares during the period. Zacks Investment Management acquired a new position in FIGS in the fourth quarter worth about $1,217,000. VARCOV Co. bought a new position in FIGS during the fourth quarter worth about $409,000. Finally, Voloridge Investment Management LLC boosted its holdings in FIGS by 77.3% during the fourth quarter. Voloridge Investment Management LLC now owns 332,960 shares of the company’s stock valued at $3,782,000 after purchasing an additional 145,135 shares in the last quarter. Institutional investors own 92.21% of the company’s stock.

FIGS News Summary

Here are the key news stories impacting FIGS this week:

• Positive Sentiment: Q4 earnings beat — FIGS reported $0.10 EPS vs. $0.02 consensus and revenue of $201.9M (up 33% YoY), signaling solid top-line momentum and margin expansion. Article Title
• Positive Sentiment: Aggressive FY2026 revenue guide — management is targeting roughly $694M–$707M (around a $700M target cited publicly), well above Street consensus (~$625.6M), and flagged international expansion and margin improvement as priorities. That guidance materially raises growth expectations. Article Title
• Positive Sentiment: Analyst upgrade — KeyCorp moved FIGS from sector weight to overweight with a $17 price target, providing third‑party validation of the company’s growth trajectory. Article Title
• Neutral Sentiment: Telsey raised its price target from $9 to $15 and set a “market perform” rating — upgrade in target, but PT sits slightly below the current share price. Article Title
• Neutral Sentiment: BTIG reaffirmed a “buy” rating with a $15 target — keeps buy conviction but target is not above the current price, limiting near-term upside from that shop. Article Title
• Neutral Sentiment: Conference call and analyst write-ups published — transcripts and call highlights provide detail on Olympic partnership, international rollout and margin levers for investors doing deeper diligence. Article Title
• Negative Sentiment: Valuation and mixed price-targets risk — FIGS trades with a high P/E and recently hit a 12‑month high, leaving shares vulnerable to profit-taking; several widely cited targets (~$15) sit at or below the current price. Article Title

About FIGS

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.